Novel insights of minocycline as a neurovascular protective agent in retinitis pigmentosa.
BACKGROUND/AIMS Retinitis pigmentosa (RP) is characterised by progressive photoreceptor degeneration accompanied by vascular abnormalities. We have previously demonstrated that minocycline exhibits therapeutic potential in RP. This trial aimed to evaluate its neurovascular protective effects. METHODS Patients with RP...